NSEUpdates19 Jun 2026 · 19 Jun 2026, 06:07 pm

Updates

Zydus Lifesciences Limited · ZYDUSLIFE

✦ AI Summary

Zydus Lifesciences Limited announced the extinguishment of 8,730,158 fully paid-up equity shares following a share buyback. These shares, with a face value of INR 1 each, were bought back at a price of INR 1,260 per share through a tender offer route. The aggregate amount for this buyback totalled INR 1,100 crore. This action reduces the company's outstanding share capital, which can potentially enhance earnings per share (EPS) and shareholder value for the remaining investors.

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Zydus Lifesciences Limited has informed the Exchange regarding 'Extinguishment Certificate'.

Attachments (1)

📄

Cadilahc_19062026180655_ExtinguishmentCertificatetoSEs19062026.pdf

pdf

Download →
View document text
June 19, 2026 BSE Limited National Stock Exchange of India Limited Department of Corporate Relations Exchange Plaza, 5th floor, Pheroze Jeejeebhoy Towers Plot No. C/1, G Block, Dalal Street, Mumbai – 400 001 Bandra-Kurla Complex, Mumbai – 400 051 Scrip Code: 532321 Symbol: ZYDUSLIFE Dear Sir/ Madam, Sub: Extinguishment of 87,30,158 (eighty seven lakh thirty thousand one hundred and fifty eight) fully paid-up equity shares having face value of INR 1/- (Indian Rupee One only) each (“Equity Shares”) of Zydus Lifesciences Limited (hereinafter referred as “the Company”) bought back at a price of INR 1,260/- (Indian Rupees One Thousand Two Hundred and Sixty only) per Equity Share for an aggregate amount not exceeding INR 1100,00,00,000/- (Indian Rupees One Thousand One Hundred Crore only) (“Buyback Size”), on a proportionate basis through tender offer route (“Buyback”), pursuant to the Securities and Exchange Board of India (Buy-Back of Securities) Regulations, 2018, as amended (“Buyback Regulations”). The number of Equity Shares bought back in the captioned Buyback and the post-buyback shareholding pattern were disclosed in the post buyback public advertisement dated June 17, 2026 which was submitted for your records on June 18, 2026. The pre and post-buyback shareholding pattern has been reproduced in Annexure A for ease of reference. In compliance with Regulations 11 and 24(iv) of the Buyback Regulations, this is to inform that the Company has extinguished 87,30,158 (eighty seven lakh thirty thousand one hundred and fifty eight) Equity Shares which were in dematerialized form. In view of the above, please see below a table showing reconciliation of the share capital of the Company (pre and post extinguishment): Sr. Particulars No. of Equity Shares Amount No. (in INR) 1. Pre-extinguishment: Issued, Subscribed and 100,62,33,990 fully 100,62,33,990 Fully Paid-Up Share Capital paid-up Equity Shares of INR 1/- each 2. Less: Equity Shares bought back and credited to our account a) Electronic Form 87,30,158 87,30,158 b) Physical Form 0 0 3. Post-extinguishment: Issued, Subscribed and 99,75,03,832 fully 99,75,03,832 Fully Paid-Up Share Capital paid-up Equity Shares of INR 1/- each We also enclose a copy of the letter dated June 18, 2026, from the National Securities Depository Limited confirming the extinguishment of 87,30,158 (eighty seven lakh thirty thousand one hundred and fifty eight) Equity Shares, as Annexure B. It is confirmed that 87,30,158 (eighty seven lakh thirty thousand one hundred and fifty eight) Equity Shares of the Company were extinguished in compliance with and according to the provisions of Regulation 11 of the Buyback Regulations. A certified true copy of the certificate dated June 19, 2026, in this regard is enclosed as Annexure C. We request you to kindly take the above on record. Thanking you, Yours sincerely, For Zydus Lifesciences Limited Dhaval N. Soni Company Secretary & Compliance Officer Membership No. FCS7063 Encl. As above. Annexure A Pre and post-Buyback shareholding pattern Category of Shareholder No. of Shares % to the No. of Shares % to the Pre-Buyback^ existing Post-Buyback* Post equity Buyback share equity capital share capital Promoter and Promoter Group and 75,46,25,314 74.99 74,82,73,673 75.01 persons acting in concert (A) Shareholding of the Non Promoter(s) 25,16,08,676 25.01 Foreign Investors (including Non 7,23,96,233 7.19 Resident Indians / FIIs/ Foreign Nationals/ Foreign Corporate Bodies) Financial Institutions/ Banks/ Mutual 11,14,15,893 11.08 24,92,30,159 24.99 Funds/ Insurance/ Government Companies Others (Individuals, Bodies Corporate, 6,77,96,550 6.74 Employees, etc.) Total (A+B) 100,62,33,990 100.00 99,75,03,832 100.00 ^ As on record date for Buyback i.e. Friday, May 29, 2026. Ref : II/CA/COM/62753/2026 June 18, 2026 Mr. Upen H. Shah Company Secretary Zydus Lifesciences Limited Zydus Tower, Satellite Cross Roads Sarkhej - Gandhinagar Highway Ahmedabad - 380015 Sub : Buy-back (tender offer) Dear Sir, As per the corporate action(s) executed by your R&T Agent/Registry Division viz; MUFG INTIME INDIA PRIVATE LIMITED , Equity Shares were credited/debited to the account(s) in the NSDL system, details of which are given below : ISIN ISIN Description D/C Records Quantity Execution Date INE010B01027 ZYDUS LIFESCIENCES LIMITED EQ NEW Debit 1 8,730,158.000 18/Jun/2026 FV RE. 1/- You may contact your R&T Agent/ Registry Division for further details in this regard. Yours faithfully, Basant Kumar Sahu Assistant Vice President